Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
This guide examines ETFs that tend to minimize taxes in taxable accounts, helping you identify tax-efficient options. Learn how to apply these picks to improve after-tax returns.
22,220 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Gallup's newest Life Evaluation Index shows more american workers struggling than thriving for the first time in the ...
Alibaba's profits falling here's headlines grab attention, but the real story is a company in transition. This guide ...
Pinterest faces headwinds after a price-target cut to $27. This story outlines three critical steps that could unlock...
A 5% pullback in the Nasdaq in 2026 echoes big past moves and offers clues about which stocks tend to fare best durin...
Chewy just popped. stock momentum followed a better-than-expected 2026 outlook, even as Q4 growth stayed modest. This...
Alphabet outpaced Amazon over the past decade in total returns, turning a $1,000 stake into roughly $7,759 vs Amazon’...
Bitcoin holds near $70,000 as macro pressures and tight liquidity push price into a narrow range ahead of a potential...
Nasdaq slides as Meta and Micron weigh on tech leadership. This deep dive keeps you informed with market moves, trend...
Beaten-down stocks often hide big upside. Explore a practical, evidence-based approach to identifying a candidate tha...
Oil markets swing as traders weigh two possible futures depending on how long a conflict will last. The uncertainty i...
A fresh Miladys loyalty pledge stirs controversy in the Ethereum community, pitting branding loyalties against core p...